No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials. (2018)
Attributed to:
Integrating innovative technologies for genotyping and phenotyping in stratified medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood-2017-08-802157
PubMed Identifier: 29229596
Publication URI: http://europepmc.org/abstract/MED/29229596
Type: Journal Article/Review
Volume: 131
Parent Publication: Blood
Issue: 4
ISSN: 0006-4971